Fever Is Mediated by Conversion of Endocannabinoid 2-Arachidonoylglycerol to Prostaglandin E₂

• Yoshihiro Kita ,

  * E-mail: kita@m.u-tokyo.ac.jp

  Affiliations Department of Lipidomics, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan, Life Sciences Core Facility, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Kenij Yoshida,

  Affiliation Department of Lipidomics, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Suzumi M. Tokuoka,

  Affiliation Department of Lipidomics, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Fumie Hamano,

  Affiliations Department of Lipidomics, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan, Life Sciences Core Facility, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Maya Yamazaki,

  Affiliation Department of Cellular Neurobiology, Brain Research Institute, Niigata University, Niigata, Niigata, Japan

  ⨯
• Kenji Sakimura,

  Affiliation Department of Cellular Neurobiology, Brain Research Institute, Niigata University, Niigata, Niigata, Japan

  ⨯
• Masanobu Kano,

  Affiliation Department of Neurophysiology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Takao Shimizu

  Affiliations Department of Lipidomics, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan, Department of Lipid Signaling, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan

  ⨯